{
    "medicine_id": "0c63eeb9e059d80edbb9d6cf255d70743a70a3fb",
    "platform_id": "DB04879",
    "metadata": {
        "name": "Galvus 50 mg Tablet",
        "composition": "50 mg Vatalanib",
        "clinical_particulars": {
            "therapeutic_indications": "Used in combination with first and second line chemotherapy for the treatment of metastatic colorectal cancer and non small cell lung cancer NSCLC",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Vatalanib is a novel oral angiogenesis inhibitor being developed by Schering in collaboration with Novartis AG Vatalanib selectively inhibits the tyrosine kinase domains of vascular endothelial growth factor VEGF receptors platelet derived growth factor PDGF receptor and c KIT",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00316",
                        "description": "The serum concentration of Acetaminophen can be increased when it is combined with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00066",
                        "description": "The therapeutic efficacy of Follitropin can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The therapeutic efficacy of Carbimazole can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The therapeutic efficacy of Methimazole can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "The therapeutic efficacy of 3 5 Diiodotyrosine can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB05084",
                        "description": "The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB06285",
                        "description": "The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB09421",
                        "description": "The therapeutic efficacy of Protirelin can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB12629",
                        "description": "The therapeutic efficacy of 3 5 diiodothyropropionic acid can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The therapeutic efficacy of Elcatonin can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Vatalanib"
                    },
                    {
                        "drugbank-id": "DB15263",
                        "description": "The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Vatalanib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}